treatment group:cisplatin

2 trials

Sponsors

Sun Yat-sen University Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

Conditions

Cervical cancerSquamous cell carcinoma of head and neck

Early Phase 1

A prospective, single-arm, single-center, phase II pilot study of sintilimab (IBI308) combined with chemotherapy as induction therapy for locally advanced head and neck squamous cell carcinoma

RecruitingChiCTR2200061313

Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical SciencesSquamous cell carcinoma of head and neck

Start: 2021-12-30Updated: 2023-04-03

Phase 2

A prospective, single-arm, phase 2 clinical trial evaluating camrelizumab combined with induction chemotherapy, concurrent chemoradiotherapy and as maintenance therapy for locally advanced cervical cancer

Active, not recruitingChiCTR2200061097

Sun Yat-sen University Cancer CenterCervical cancer

Start: 2022-06-01Updated: 2023-03-26

Related Papers

Neoadjuvant chemo-immunotherapy following concurrent immuno-chemoradiotherapy and immune-maintenance therapy as primary treatment for locally advanced cervical cancer: A prospective, single-arm, phase 2 trial.

Journal of Clinical Oncology2024-06-011 citations